Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

Pfizer Inc (PFE) stock saw a decline, ending the day at $26.3 which represents a decrease of $-0.19 or -0.72% from the prior close of $26.49. The stock opened at $26.4 and touched a low of $26.22 ...

The company has a forward P/E ratio of 11.5 while Merck, Eli Lilly, and Novo Nordisk have multiples of 14.8, 64, and 40.5.

Every investor in Pfizer Inc. ( NYSE:PFE) should be aware of the most powerful shareholder groups. We can see that ...

Pfizer (PFE) is one of the stocks most watched by ... has resulted in a Zacks Rank #2 (Buy) for Pfizer. The chart below shows the evolution of the company's forward 12-month consensus EPS estimate ...

We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not ...

PFE returned $7.1 billion via dividends in 9M-24, while reducing debt by $4.4 billion through balance sheet optimization. Investing $10.7-$11.7 billion in R&D, focusing on obesity treatments ...

Pfizer (PFE) is one of the stocks most watched by ... of earnings is what determines the fair value for its stock. Our analysis is essentially based on how sell-side analysts covering the stock ...

Johnson & Johnson offers safer payouts and stronger growth. Discover why JNJ stock is the better dividend option compared to ...

Citi analyst Geoff Meacham maintained a Hold rating on Pfizer (PFE – Research Report) today. The company’s shares closed yesterday at ...

PFE) is off about 0.5%, and ConocoPhillips (Symbol: COP) is lower by about 0.8%. For a complete list of holdings, visit the IWB Holdings page » The chart below shows the one year price ...